Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05085535Not ApplicableWithdrawn

Study of Manual Therapy Plus Therapeutic Exercise in Geriatrics

Role: collaborator

NCT03939416Not ApplicableWithdrawn

Study of the Influence of POLD Manual Therapy in Fibromyalgia

Role: lead

NCT06378944Recruiting

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

Role: lead

NCT05280353Not ApplicableRecruiting

Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain

Role: lead

NCT01591824Not ApplicableCompleted

Study of Effectiveness of Pold in Chronic Nonspecific Low Back Pain

Role: lead

NCT03669952Completed

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer

Role: lead

All 6 trials loaded